Flora Alarcon
Impact in
-
- Parathyroid Disorders and Treatments
-
- Genetic factors in colorectal cancer
Papers in
- Genetics 10
- Genetic Associations and Epidemiology 5
- Dermatological and Skeletal Disorders 3
- BRCA gene mutations in cancer 3
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 7
- Protein Kinase Regulation and GTPase Signaling 2
- Co-authors
- Catherine Bonaïti‐Pellié (7 shared papers)Violaine Planté‐Bordeneuve (10 shared papers)Urban Hellman (1 shared paper)Ole B. Suhr (2 shared papers)Grégory Nuel (9 shared papers)Bernard Bonaïti (3 shared papers)Hervé Perdry (4 shared papers)Valérie Bonadona (3 shared papers)
In The Last Decade
Flora Alarcon
19 papers receiving 313 citations
Peers
Comparison fields: 5 of 55
- Nephrology 38
- Pathology and Forensic Medicine 74
- Genetics 96
- Cell Biology 56
- Molecular Biology 221
Countries citing papers authored by Flora Alarcon
This map shows the geographic impact of Flora Alarcon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Flora Alarcon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Flora Alarcon more than expected).
Fields of papers citing papers by Flora Alarcon
This network shows the impact of papers produced by Flora Alarcon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Flora Alarcon. The network helps show where Flora Alarcon may publish in the future.
Co-authors
The 25 scholars most cited alongside Flora Alarcon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 138 | |
| 2 | 2007 | 50 | |
| 3 | 2009 | 24 | |
| 4 | 2020 | 23 | |
| 5 | 2001 | 18 | |
| 6 | 2008 | 16 | |
| 7 | 2020 | 15 | |
| 8 | 2011 | 9 | |
| 9 | 2017 | 6 | |
| 10 | 2018 | 5 | |
| 11 | 2018 | 4 | |
| 12 | 2023 | 4 | |
| 13 | 2013 | 4 | |
| 14 | 2015 | 3 | |
| 15 | 2023 | 2 | |
| 16 | 2018 | 2 | |
| 17 | 2023 | 1 | |
| 18 | 2008 | 1 | |
| 19 | 2018 | 1 |
About Flora Alarcon
Flora Alarcon is a scholar working on Genetics, Molecular Biology, Pathology and Forensic Medicine, Cancer Research and Rheumatology, having authored 19 papers that have together received 326 indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (7 papers), Genetic factors in colorectal cancer (6 papers), Genetic Associations and Epidemiology (5 papers), Cancer Genomics and Diagnostics (4 papers), Dermatological and Skeletal Disorders (3 papers), BRCA gene mutations in cancer (3 papers), Eosinophilic Disorders and Syndromes (3 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). The work is most often cited by research in Nephrology (38 citations), Pathology and Forensic Medicine (74 citations), Genetics (96 citations), Cell Biology (56 citations) and Molecular Biology (221 citations). Flora Alarcon has collaborated with scholars based in France, Sweden and Spain. Frequent co-authors include Catherine Bonaïti‐Pellié, Violaine Planté‐Bordeneuve, Urban Hellman, Ole B. Suhr, Grégory Nuel, Bernard Bonaïti, Hervé Perdry, Valérie Bonadona, Jérôme Carayol and Christine Lasset. Their work appears in journals such as Amyloid, Genetic Epidemiology, PLoS ONE, Orphanet Journal of Rare Diseases and European Journal of Human Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.